论文部分内容阅读
本文采用中草药复方制剂──生白宝口服液治疗因放、化疗引起的白细胞减少症的恶性肿瘤患者54例,一周有效率达75.9%,治疗一周前后白细胞均值增加1.6×109/L。与对照组相比差异非常显著。并且试验组中初治病人和复治病人的疗效都显著优于对照组,尤其以试验组初治病人最为突出,一周有效率为84.4%。表明生白宝口服液具有快速、高效提升白细胞的特点,且毒副作用轻微。
In this article, 54 cases of malignant neoplasms caused by radiotherapy and chemotherapy were treated with Shengbaibao Oral Liquid, a Chinese herbal compound preparation. The effective rate was 75.9% in one week, and the mean WBC increased by 1.6×109/week before and after one week of treatment. L. The difference was very significant compared to the control group. In addition, the efficacy of the initial and retreatment patients in the trial group was significantly better than that in the control group, especially in the initial group of the trial group. The effective rate in the week was 84.4%. It shows that Shengbaibao oral liquid has the characteristics of rapid and efficient leukocyte, and has slight side effects.